Lantus-(Vial) · DIN 02245689 · 100U/mL · injection solution-10mL vial
Limited Use, Reason for Use code 644 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 644 required
Write on scriptReason for Use code 644 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 644
Reason for Use code 644
Patient requires insulin therapy and is unable to use the insulin pen.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Lantus-(Vial) · DIN 02245689
Manufacturer: Sanofi Aventis Pharma; listing date 2008-12-03
Health Canada: Marketed since 2007-10-23 · brand LANTUS · ATC A10AE04 INSULIN GLARGINE · form Solution · route Subcutaneous · ingredients INSULIN GLARGINE 100 UNIT/ML · company Sanofi-aventis canada inc · schedule Schedule d
Re-check Health Canada status and shortages (live) · Health Canada product recordLantus-(Vial): Formulary list price $61.69 per unit (the source does not state the unit; exact figure $61.6900). What the ministry pays, not the patient.
Ministry pays: $61.6900 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245689)
Source record
DIN 02245689: Lantus-(Vial)
Raw flags: insOH=Y, sec12=Y, sec3=Y
Item: 682014009; group id 781; item number 1901; lccId 00367; manufacturer id SAV
Source form: Inj Sol-10mL Vial Pk; strength: 100U/mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; diabetes medication flag
Source prices (unrounded): $61.6900; ministry $61.6900
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245689
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69790
Shortage status: resolved shortage (ended September 13, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245689
Shortage record checked October 6, 2026